Adell Harriman & Carpenter’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.17M | Buy |
291,128
+18,230
| +7% | +$485K | 0.5% | 45 |
|
|
2025
Q4 | $6.8M | Buy |
272,898
+18,009
| +7% | +$454K | 0.41% | 46 |
|
|
2025
Q3 | $6.49M | Buy |
254,889
+45,578
| +22% | +$1.12M | 0.39% | 49 |
|
|
2025
Q2 | $5.07M | Buy |
209,311
+60,326
| +40% | +$1.41M | 0.34% | 57 |
|
|
2025
Q1 | $3.78M | Buy |
148,985
+139,829
| +1,527% | +$3.66M | 0.28% | 69 |
|
|
2024
Q4 | $243K | Sell |
9,156
-9,240
| -50% | -$251K | 0.02% | 156 |
|
|
2024
Q3 | $532K | Buy |
18,396
+1,410
| +8% | +$41.1K | 0.04% | 120 |
|
|
2024
Q2 | $475K | Sell |
16,986
-15,587
| -48% | -$429K | 0.04% | 125 |
|
|
2024
Q1 | $904K | Sell |
32,573
-46,249
| -59% | -$1.28M | 0.07% | 103 |
|
|
2023
Q4 | $2.27M | Sell |
78,822
-55,825
| -41% | -$1.69M | 0.21% | 81 |
|
|
2023
Q3 | $4.47M | Sell |
134,647
-17,919
| -12% | -$634K | 0.46% | 59 |
|
|
2023
Q2 | $5.59M | Buy |
152,566
+7,077
| +5% | +$275K | 0.57% | 52 |
|
|
2023
Q1 | $5.94M | Sell |
145,489
-3,840
| -3% | -$166K | 0.64% | 54 |
|
|
2022
Q4 | $7.65M | Sell |
149,329
-3,188
| -2% | -$153K | 0.88% | 44 |
|
|
2022
Q3 | $6.67M | Sell |
152,517
-4,325
| -3% | -$210K | 0.81% | 44 |
|
|
2022
Q2 | $8.22M | Buy |
156,842
+5,800
| +4% | +$296K | 1.01% | 36 |
|
|
2022
Q1 | $7.82M | Sell |
151,042
-2,288
| -1% | -$119K | 0.76% | 43 |
|
|
2021
Q4 | $9.05M | Sell |
153,330
-1,905
| -1% | -$94.4K | 0.84% | 40 |
|
|
2021
Q3 | $6.68M | Buy |
155,235
+6,097
| +4% | +$270K | 0.7% | 48 |
|
|
2021
Q2 | $5.84M | Buy |
149,138
+21,818
| +17% | +$848K | 0.61% | 53 |
|
|
2021
Q1 | $4.61M | Buy |
127,320
+2,530
| +2% | +$89.8K | 0.56% | 59 |
|
|
2020
Q4 | $4.59M | Buy |
124,790
+11,184
| +10% | +$410K | 0.6% | 57 |
|
|
2020
Q3 | $3.96M | Buy |
113,606
+1,644
| +1% | +$57.6K | 0.59% | 53 |
|
|
2020
Q2 | $3.47M | Sell |
111,962
-2,925
| -3% | -$99.4K | 0.59% | 52 |
|
|
2020
Q1 | $3.56M | Sell |
114,887
-26,500
| -19% | -$903K | 0.75% | 44 |
|
|
2019
Q4 | $5.26M | Sell |
141,387
-1,838
| -1% | -$65.5K | 0.86% | 42 |
|
|
2019
Q3 | $4.88M | Sell |
143,225
-38,283
| -21% | -$1.39M | 0.88% | 37 |
|
|
2019
Q2 | $7.46M | Sell |
181,508
-591
| -0.3% | -$23.5K | 1.39% | 25 |
|
|
2019
Q1 | $7.34M | Buy |
182,099
+433
| +0.2% | +$17.3K | 1.43% | 24 |
|
|
2018
Q4 | $7.52M | Sell |
181,666
-728
| -0.4% | -$30.2K | 1.66% | 22 |
|
|
2018
Q3 | $7.63M | Buy |
182,394
+2,935
| +2% | +$113K | 1.43% | 24 |
|
|
2018
Q2 | $6.18M | Sell |
179,459
-4,623
| -3% | -$158K | 1.22% | 30 |
|
|
2018
Q1 | $6.2M | Buy |
184,082
+34,699
| +23% | +$1.19M | 1.29% | 28 |
|
|
2017
Q4 | $5.13M | Sell |
149,383
-1,440
| -1% | -$49.1K | 1.09% | 33 |
|
|
2017
Q3 | $5.11M | Sell |
150,823
-9,544
| -6% | -$307K | 1.12% | 32 |
|
|
2017
Q2 | $5.11M | Sell |
160,367
-24,494
| -13% | -$772K | 1.16% | 34 |
|
|
2017
Q1 | $6M | Sell |
184,861
-8,795
| -5% | -$277K | 1.38% | 25 |
|
|
2016
Q4 | $5.97M | Sell |
193,656
-7,019
| -3% | -$214K | 1.49% | 24 |
|
|
2016
Q3 | $6.45M | Buy |
200,675
+229
| +0.1% | +$7.66K | 1.63% | 19 |
|
|
2016
Q2 | $6.7M | Buy |
200,446
+12,435
| +7% | +$397K | 1.75% | 14 |
|
|
2016
Q1 | $5.29M | Buy |
188,011
+2,303
| +1% | +$65.8K | 1.42% | 28 |
|
|
2015
Q4 | $5.69M | Buy |
185,708
+33,999
| +22% | +$1.07M | 1.53% | 22 |
|
|
2015
Q3 | $4.52M | Buy |
151,709
+3,057
| +2% | +$98K | 1.33% | 22 |
|
|
2015
Q2 | $4.73M | Buy |
148,652
+11,436
| +8% | +$373K | 1.22% | 27 |
|
|
2015
Q1 | $4.53M | Buy |
137,216
+13,302
| +11% | +$423K | 1.19% | 28 |
|
|
2014
Q4 | $3.66M | Buy |
123,914
+67,504
| +120% | +$1.94M | 1% | 36 |
|
|
2014
Q3 | $1.59M | Hold |
56,410
| – | – | 0.44% | 72 |
|
|
2014
Q2 | $1.59M | Buy |
56,410
+6,063
| +12% | +$173K | 0.44% | 72 |
|
|
2014
Q1 | $1.53M | Buy |
50,347
+19,227
| +62% | +$573K | 0.45% | 69 |
|
|
2013
Q4 | $904K | Buy |
31,120
+751
| +2% | +$21.9K | 0.28% | 76 |
|
|
2013
Q3 | $828K | Buy |
30,369
+3,715
| +14% | +$101K | 0.23% | 77 |
|
|
2013
Q2 | $708K | Buy |
+26,654
| New | +$736K | 0.25% | 78 |
|
Other funds holding PFE
VCM
VPM
Adell Harriman & Carpenter's PFE Position: Q1 2026 in Review
Adell Harriman & Carpenter increased its Pfizer (PFE) stake by 6.7% in Q1 2026, buying an estimated $485K and bringing the position to 291,128 shares worth $8.17M. The position accounts for 0.5% of the portfolio, ranked #45.
Adell Harriman & Carpenter first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $9.05M in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Adell Harriman & Carpenter held 291,128 shares of Pfizer worth $8.17M as of Q1 2026.
- Adell Harriman & Carpenter bought 18,230 Pfizer shares in Q1 2026, an estimated $485K.
- Pfizer made up 0.5% of Adell Harriman & Carpenter's portfolio in Q1 2026, its #45 holding.
- Adell Harriman & Carpenter first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Adell Harriman & Carpenter's Pfizer position peaked at $9.05M in Q4 2021.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Adell Harriman & Carpenter's 13F filing for Q1 2026, filed 4 May 2026.